The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ultrasound Screening for Ovarian Cancer: Are We There Yet?
Open accessAbstract
Drs. Robertson and Peipert are from the Department of Obstetrics & Gynecology at the Indiana University School of Medicine, Indianapolis, IN; email: [email protected]. Financial Disclosure Dr. Peipert has served on Advisory Boards for CooperSurgical/Teva and has received research funding and support from Merck, Bayer, and CooperSurgical/Teva. The other author did not report any potential conflicts of interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“routine screening for ovarian cancer in average-risk women utilizing transvaginal ultrasound, cancer antigen 125 (CA-125) testing, or their combination has no significant effect on ovarian cancer mortality [38]”
From Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants (2026) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
Research works printed but not linked: 6
- Buys, 2011, Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial, JAMA, 305, 2295, 10.1001/jama.2011.766 · DOI
- Kobayashi, 2008, A randomized study of screening for ovarian cancer: a multicenter study in Japan, Int J Gynecol Cancer, 18, 414, 10.1111/j.1525-1438.2007.01035.x · DOI
- van Nagell, 2011, Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening, Obstet Gynecol, 118, 1212, 10.1097/AOG.0b013e318238d030 · DOI
- Henderson, 2018, Screening for ovarian cancer: updated evidence report and systematic review for the US Preventive Services Task Force, JAMA, 319, 595, 10.1001/jama.2017.21421 · DOI · Paper page
- van Nagell, 2018, Survival of women with type I and II epithelial ovarian cancer detected by ultrasound screening, Obstet Gynecol, 132, 1091, 10.1097/AOG.0000000000002921 · DOI
- Rosenthal, 2017, Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study, J Clin Oncol, 35, 1411, 10.1200/JCO.2016.69.9330 · DOI
Cited by
Sorted by citations
Abdel-Razeq, H., & Mansour, R. (2026) · World Journal of Oncology · doi:10.14740/wjon2692
Metadata
- Authors
- Robertson, S. E., & Peipert, J. F.
- Affiliations
- Indiana University Indianapolis (US)
- ORCID
- Robertson, Sharon E.
- Venue
- Obstetrics & Gynecology
- Published
- 2018-11
- Volume
- 132
- Issue
- 5
- Pages
- 1089-1090
- ISSN
- 0029-7844 (ISSN-L)
- 1873-233X
- OpenAlex
- W2897019199
- Cited by
- 6
- References
- 1
- Citations by year
- 2025: 1 · 2021: 1 · 2020: 2
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- ovarian cancer, ultrasound screening, transvaginal ultrasound, early detection, gynecologic cancer screening
- MeSH terms
- Carcinoma, Ovarian Epithelial, Female, Humans, Mass Screening, Ovarian Neoplasms, Ultrasonography, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ultrasound Screening for Ovarian Cancer: Are We There Yet? https://app.cochat.ai/papers/10.1097/aog.0000000000002962
- The paper
- Robertson, S. E., & Peipert, J. F. (2018). Ultrasound Screening for Ovarian Cancer: Are We There Yet? Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000002962
